Cargando…
Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients
Autores principales: | Zampieri, Fernando G., Ginde, Adit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887006/ https://www.ncbi.nlm.nih.gov/pubmed/34910598 http://dx.doi.org/10.1164/rccm.202111-2593ED |
Ejemplares similares
-
Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin
por: Hetzer, Sonja, et al.
Publicado: (2014) -
Tracheostomy Practices for Mechanically Ventilated Patients in Malawi
por: Prin, Meghan, et al.
Publicado: (2021) -
The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial
por: Legrand, Matthieu, et al.
Publicado: (2020) -
Making Sense of OA
por: Markovac, J., et al.
Publicado: (2015) -
Making sense of Cronbach's alpha
por: Tavakol, Mohsen, et al.
Publicado: (2011)